Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuo-Cheng Lu

Showing results (121-130 of 236) with videos related to

Pageof 24
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|December 8, 2011
Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese populationSui-Lung Su, Kuo-Cheng Lu, Yuh-Feng Lin, et al.
International Journal of Medical Sciences|January 2, 2025
Therapeutic potential of <i>Astragalus</i>-based Eefooton in patients with chronic kidney disease: from clinical to bench studyKuo-Cheng Lu, Ko-Lin Kuo, San-Chiang Wu, et al.
Medicine|June 30, 2021
Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort studyChien-Lin Lu, Chien-Yu Lin, Lian-Yu Lin, et al.
Oncotarget|January 18, 2018
Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathyYen-Sung Huang, Shin-Huei Fu, Kuo-Cheng Lu, et al.
Renal Failure|July 16, 2025
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targetsChia-Ter Chao, Yi-Chou Hou, Min-Tser Liao, et al.
International Journal of Molecular Sciences|June 12, 2026
Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary HyperparathyroidismMin-Tser Liao, Chia-Chao Wu, Yi-Chou Hou, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Circadian Influences on Chronic Kidney Disease Progression: Molecular Signaling Pathways of Melatonin and Their Therapeutic PotentialKuo-Cheng Lu, Chien-Lin Lu, Yi-Chou Hou, et al.
Frontiers in Nutrition|July 7, 2022
A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19Wen-Lin Su, Chia-Chao Wu, Shu-Fang Vivienne Wu, et al.
Biomedicines|July 29, 2023
The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney DiseaseKuo-Chin Hung, Wei-Cheng Yao, Yi-Lien Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 22, 2010
Glycated albumin is independently associated with estimated glomerular filtration rate in nondiabetic patients with chronic kidney diseaseWen-Ya Ma, Chia-Chao Wu, Dee Pei, et al.
Pageof 24

Showing results (121-130 of 236) with videos related to

Sort By:
Pageof 24
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|December 8, 2011
Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese populationSui-Lung Su, Kuo-Cheng Lu, Yuh-Feng Lin, et al.
International Journal of Medical Sciences|January 2, 2025
Therapeutic potential of <i>Astragalus</i>-based Eefooton in patients with chronic kidney disease: from clinical to bench studyKuo-Cheng Lu, Ko-Lin Kuo, San-Chiang Wu, et al.
Medicine|June 30, 2021
Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort studyChien-Lin Lu, Chien-Yu Lin, Lian-Yu Lin, et al.
Oncotarget|January 18, 2018
Inhibition of tumor necrosis factor signaling attenuates renal immune cell infiltration in experimental membranous nephropathyYen-Sung Huang, Shin-Huei Fu, Kuo-Cheng Lu, et al.
Renal Failure|July 16, 2025
Adynamic bone disorder in chronic kidney disease: meta-analysis and narrative review of potential biomarkers as diagnosis and therapeutic targetsChia-Ter Chao, Yi-Chou Hou, Min-Tser Liao, et al.
International Journal of Molecular Sciences|June 12, 2026
Pre-Parathyroidectomy PTH as an Integrated Biomarker of Glandular Remodeling and Skeletal Turnover in Secondary HyperparathyroidismMin-Tser Liao, Chia-Chao Wu, Yi-Chou Hou, et al.
Pharmaceuticals (Basel, Switzerland)|June 26, 2026
Circadian Influences on Chronic Kidney Disease Progression: Molecular Signaling Pathways of Melatonin and Their Therapeutic PotentialKuo-Cheng Lu, Chien-Lin Lu, Yi-Chou Hou, et al.
Frontiers in Nutrition|July 7, 2022
A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19Wen-Lin Su, Chia-Chao Wu, Shu-Fang Vivienne Wu, et al.
Biomedicines|July 29, 2023
The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney DiseaseKuo-Chin Hung, Wei-Cheng Yao, Yi-Lien Liu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 22, 2010
Glycated albumin is independently associated with estimated glomerular filtration rate in nondiabetic patients with chronic kidney diseaseWen-Ya Ma, Chia-Chao Wu, Dee Pei, et al.
Pageof 24